Cargando…

P26 LANDSCAPE OF RECURRENT CYTOGENETIC ABNORMALITIES IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA AS DETECTED BY CHROMOSOME MICROARRAY ANALYSIS (CMA)

Detalles Bibliográficos
Autores principales:	Varshavsky Yanovsky, A., Shestovska, Y., Pei, J., Mackrides, N., Fung, H., Nejati, R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Poster
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171716/ http://dx.doi.org/10.1097/01.HS9.0000936232.91634.31

Ejemplares similares

Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma
por: Binder, M, et al.
Publicado: (2017)

Abnormalities in spontaneous abortions detected by G-banding and chromosomal microarray analysis (CMA) at a national reference laboratory
por: Wang, Boris T, et al.
Publicado: (2014)

Long contiguous stretches of homozygosity detected by chromosomal microarrays (CMA) in patients with neurodevelopmental disorders in the South of Brazil
por: Chaves, Tiago Fernando, et al.
Publicado: (2019)

Development and validation of prognostic implications of chromosome abnormalities algorithm for newly diagnosed multiple myeloma
por: Luo, Tiancheng, et al.
Publicado: (2020)

Recent Developments at the CMA: 2020–2021
por: Bon, Julie, et al.
Publicado: (2021)

Molecular cytogenetic identification of small supernumerary marker chromosomes using chromosome microarray analysis
por: Xue, Huili, et al.
Publicado: (2019)

Competing endogenous RNA network in newly diagnosed multiple myeloma by genetic microarray
por: He, Yu-Qin, et al.
Publicado: (2020)

Cytogenetic abnormality in patients with multiple myeloma analyzed by fluorescent in situ hybridization
por: Hu, Ying, et al.
Publicado: (2016)

Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response
por: Abdallah, Nadine, et al.
Publicado: (2020)

Uncovering the Genomic Landscape in Newly Diagnosed and Relapsed Pediatric Cytogenetically Normal FLT 3‐ITD AML
por: Buelow, Daelynn R., et al.
Publicado: (2019)

Clinical Significance of TP53 Abnormalities in Newly Diagnosed Multiple Myeloma
por: Ye, Fang, et al.
Publicado: (2021)

InfectionCMA: A Cell MicroArray Approach for Efficient Biomarker Screening in In Vitro Infection Assays
por: Magalhães, Ana C., et al.
Publicado: (2022)

PB2023: UPDATE AND FOLLOW-UP OF NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) WITH HIGH-RISK CYTOGENETIC (HRC).
por: Nuevo López, M. I., et al.
Publicado: (2022)

Evaluating the Clinical Utility of Genome Sequencing for Cytogenetically Balanced Chromosomal Abnormalities in Prenatal Diagnosis
por: Yu, Mullin Ho Chung, et al.
Publicado: (2021)

PB2038: LENALIDOMIDE OR BORTEZOMIB AS MAINTENANCE TREATMENT OVERCOMES INFERIOR IMPACT OF HIGH-RISK CYTOGENETIC ABNORMALITIES IN TRANSPLANT-INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA IN CHINA
por: Zhuang, Z., et al.
Publicado: (2022)

The Landscape of Cytogenetic Aberrations in Light-Chain Amyloidosis with or without Coexistent Multiple Myeloma
por: He, Haiyan, et al.
Publicado: (2023)

The landscape of small nucleolar RNA expression in multiple myeloma is determined by cytogenetic alterations
por: Zhao, Duoduo, et al.
Publicado: (2023)

Cytogenetic Abnormalities in Multiple Myeloma Patients at a Tertiary Healthcare Center in India
por: Govindasamy, Perumal, et al.
Publicado: (2019)

Combined Use of Cytogenetic and Molecular Methods in Prenatal Diagnostics of Chromosomal Abnormalities
por: Stomornjak-Vukadin, Meliha, et al.
Publicado: (2015)

CMA: how long does it last for?
por: Papadopoulos, Nikolaos
Publicado: (2011)

Recent Developments at the CMA: 2019–2020
por: Havell, Richard, et al.
Publicado: (2020)

Recent Developments at the CMA: 2021–22
por: Cellan-Jones, Adam, et al.
Publicado: (2022)

Additional cytogenetic abnormalities in patients with newly diagnosed acute promyelocytic leukemia predict inferior event‐free survival
por: Zeng, Hui, et al.
Publicado: (2023)

A retrospective analysis of cytogenetic alterations in patients with newly diagnosed multiple myeloma: a single center study in Korea
por: Li, Shuhua, et al.
Publicado: (2016)

P-208: Association of thrombocytopenia with disease burden, high-risk cytogenetics, and survival in newly diagnosed multiple myeloma patients
por: Charalampous, Charalampos, et al.
Publicado: (2022)

Age and cytogenetic abnormalities()
por: Souza, Cármino Antonio de
Publicado: (2018)

Cytogenetic microarray in prenatal and postnatal diagnosis
por: Phadke, Shubha
Publicado: (2014)

Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center study
por: Greenberg, A J, et al.
Publicado: (2015)

Prognostic Impact of Cytogenetic Abnormalities in Multiple Myeloma: A Retrospective Analysis of 229 Patients
por: Jian, Yuan, et al.
Publicado: (2016)

Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center study
por: Greenberg, A J, et al.
Publicado: (2015)

Cytogenetic abnormalities correlate with clinico-biological characteristics in 30 Moroccan multiple myeloma patients
por: Hamdaoui, Hasna, et al.
Publicado: (2023)

P940: AN OUTPATIENT MODEL FOR TECLISTAMAB STEP-UP DOSING ADMINISTRATION – INITIAL EXPERIENCES AT FOX CHASE CANCER CENTER BMT PROGRAM.
por: Nina Varshavsky-Yanovsky, Asya, et al.
Publicado: (2023)

Trisomy Chromosome 6 as a Sole Cytogenetic Abnormality in Acute Myeloid Leukemia
por: Gupta, Monika, et al.
Publicado: (2015)

Prognostic value of integrated cytogenetic, somatic variation, and copy number variation analyses in Korean patients with newly diagnosed multiple myeloma
por: Lee, Nuri, et al.
Publicado: (2021)

The impact of bortezomib-based induction in newly diagnosed multiple myeloma with chromosome 1q21 gain
por: Tang, Hoi Ki Karen, et al.
Publicado: (2022)

Summary of CMA glycol ether research activities.
por: Lyon, J P
Publicado: (1984)

The Multifaceted Role of CMA in Glioma: Enemy or Ally?
por: Lo Dico, Alessia, et al.
Publicado: (2021)

Minority of doctors block CMA diversity overhaul
por: Duong, Diana
Publicado: (2021)

The impact of CMA budget cuts on CMAJ Group
por: Patrick, Kirsten
Publicado: (2023)

CMA mediates resistance in breast cancer models
por: Lo Dico, Alessia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bmoopn3f4163jq97f7olprndao